MBC-31

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMBC-31
Drug Alias Namealendronate-vitamin B6 conjugate (MBC Pharma)conjugated bisphosphonates (MBC Pharma)MBC-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMbc Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMbc Pharma Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A